Evidence map›Paper›PMID 38273301›Full record

ArticleFluids and barriers of the CNS2024

Application of a new MDCKII-MDR1 cell model to measure the extent of drug distribution in vitro at equilibrium for prediction of in vivo unbound brain-to-plasma drug distribution.

Kristine Langthaler, Christopher R Jones, Lasse Saaby, Christoffer Bundgaard, Birger Brodin

Open access · goldAbstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in pharmacology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kristine LangthalerTranslational DMPK, H. Lundbeck A/S, and CNS Drug Delivery and Barrier Modelling, University of Copenhagen, Ottiliavej 9, Valby, 2500, Copenhagen, Denmark. KRIE@lundbeck.com.
Christopher R JonesPKPD Modelling & Simulation, H. Lundbeck A/S, Ottiliavej 9, Valby, 2500, Copenhagen, Denmark.
Lasse SaabyBioneer A/S and affiliated associate professor at CNS Drug Delivery and Barrier Modelling, Universitetsparken 2, 2100, Copenhagen, Denmark.
Christoffer BundgaardTranslational DMPK, H. Lundbeck A/S, Ottiliavej 9, Valby, 2500, Copenhagen, Denmark.
Birger BrodinCNS Drug Delivery and Barrier Modelling, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark.
Lundbeck (Denmark) · DKBioneer (Denmark) · DKUniversity of Copenhagen · DK

Funding

Innovationsfonden 9065-00189B
6 · The paper itself

Abstract

introReliable estimates of drug uptake from blood to brain parenchyma are crucial in CNS drug discovery and development. While in vivo K

methodsIn vitro equilibrium distribution studies were conducted in apical and basolateral solutions with high protein content to estimate K

resultsWe observed a good correlation between in vitro and in vivo K

conclusionThe in vitro assay setup developed in this study holds promise for predicting in vivo drug brain penetration in CNS drug discovery. The correlation between in vitro and in vivo K

Indexed as

Blood-Brain BarrierBrainAnimalsBiological Transport

Identifiers

PMID38273301
PMCPMC10809502
OpenAlexW4391229038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.